About Us
Overview
Our Business
Board of Directors
Executive Leadership Team
Our Stories
Biocon Biologics Malaysia
Scientific Publications
Awards & Recognition
Our Legacy
Business
Global Biosimilars Portfolio
Oncology
Immunology
Diabetology
Ophthalmology
Bone Health & Others
Our Products
Global
India
Partners
Global Footprint
Capabilities
Research & Development
Quality & Compliance
Global Scale Manufacturing
Commitment
Investors
News
Press Releases
Company Statements
Our Stories
Media Contacts
Careers
Working With Us
Now Hiring
Contact Us
Press Releases 2023
Biocon Biologics
/
News – Posts
/
Press Releases
/
Press Releases 2023
Biocon Biologics Wins the ‘ABEA : Bioprocessing Excellence in South Asia’ Award
Tue, 28-Mar-2023
Posted by: Biocon Biologics
No Comments
Biocon Q3FY23 Revenue at Rs 3,020 Cr, Up 36%; Biosimilars Up 54%; Research Services Up 23%; Generics Up 18%
Thu, 09-Mar-2023
Posted by: Biocon Biologics
No Comments